According to information from Taxotere class action lawsuits, the cancer drug may cause alopecia. Any women who has alopecia understands how hard it can be difficult to find the best make up and the application techniques to help you look and feel your best. Here we offer some great makeup tips for your eyes to start you on your journey. Eyebrows One of the most … [Read more...]
What is Alopecia?
Alopecia is a condition that causes the hair on your scalp, face, or body to fall out. The severity of alopecia can range from mild to severe so the condition has a variety of “types.” While the condition generally presents with your hair falling out in round patches on some area of the body that normally grows hair. Patients who are treated with a certain cancer treatment … [Read more...]
Comparison of Cancer Medications
Paclitaxel, sold under the brand name Taxol, and Docetaxel, sold under the brand name Taxotere are both taxane chemotherapy drugs used to treat advanced and metastatic breast cancer. They are also used in the treatment of prostate cancer, non-small cell lung cancer, melanoma, and bladder and ovarian cancers.Unfortunately, according to current litigation filed by Taxotere … [Read more...]
What is Taxotere Used For?
Taxotere is an anticancer medication that inhibits the spread of cancer cells through the body. The medication is given intravenously with a dose and schedule designed by your physician and based on numerous factors including your weight, height, general health, and the specific type of cancer you’re being treated for. However, Taxotere hair loss attorneys have pursued … [Read more...]
Taxotere Lawsuit, Settlement and Compensation Info
The Facts More than 2.8 million women in the U.S. have a history of breast cancer, including those receiving treatment and those who have completed their treatments. For each of them, whether they are tomboys, glamour girls, or somewhere in the middle, their hair is part of who they are. It’s their mane and their crown. Most women have to make peace with the fact that … [Read more...]